Zellerbach files suit against Goldsmith seeking injunction to halt bid, Goldsmith files suit to block anti-takeover measures
Category: Businessman: Investor
Goldsmith abandons bid
Goldsmith ends bid for Zellerbach, but reserves right to reopen the bid
Goldsmith drops 1.2bn bid for Crown Zellerbach
Goldsmith ends bid for Zellerbach, but reserves right to reopen the bid and seeks representation on board, Crown announces major restructure
Goldsmith gives Crown a breather
Goldsmith ends bid for Zellerbach, but reserves right to reopen the bid and seeks representation on board, Crown announces major restructure
Goldsmith increases stake in Crown Zellerbach by 4.5 percent
Goldsmith purchases more than 1.2 million Crown Zellerbach shares, raising holding to nearly 25 per cent, and questions restructuring plan
“Goldsmith increases stake in Crown Zellerbach by 4.5 percent”
Goldsmith increases stake in Crown Zellerbach to 19.6 percent
General Oriental raises stake in Zellerbach
“Goldsmith increases stake in Crown Zellerbach to 19.6 percent”
Crown Zellerbach holders support board, Creson says
Zellerbach’s chairman claims shareholders support current board, Goldsmith contends holders voted to give his partnership minority representation on board
Goldsmith fails in board bid
Goldsmith does not win boards on Crown Zellerbach board at annual meeting
Goldsmith trips poison pill issued by Crown Zellerbach
Goldsmith triggers poison-pill rights issued by Crown Zellerbach by buying more stock to take him over 20 percent threshold, potentially blocking a merger with another company
Crown Zellerbach’s defense is questioned
Goldsmith boosts stake in Zellerbach to more than 20 percent, casts doubt on poison pill defense
Crown Zellerbach concedes poison pill is irreversible
Zellerbach concedes poison pill is irreversible, Goldsmith says it will hurt restructuring programme
Goldsmith urged to relent by CZ
Crown Zellerbach chairman William Creson urges Goldsmith not to interfere with will of Crown’s shareholders, Goldsmith drops bid
Curzon boosts Aspinall profit to 6.9m midway
Aspinall Holdings lifts profits by 86 per cent
Goldsmith’s battle for Crown Zellerbach control continues
Goldsmith triggers poison-pill rights issued by Crown Zellerbach by buying more stock to take him over 20 percent threshold, potentially blocking a merger with another company
Crown Zellerbach, Goldsmith agree to restructuring truce
Goldsmith and Crown Zellerbach agree to cooperate on restructuring, providing Goldsmith is elected to the board
Goldsmith calls truce in US bid
Goldsmith and Crown Zellerbach agree to cooperate on restructuring, providing Goldsmith is elected to the board
Goldsmith on Crown board after settlement
Goldsmith and Crown Zellerbach agree to cooperate on restructuring, providing Goldsmith is elected to the board
Goldsmith reaches accord with Crown
Goldsmith and Crown Zellerbach agree to cooperate on restructuring, providing Goldsmith is elected to the board
Goldsmith sets a peace accord with Zellerbach
Goldsmith and Crown Zellerbach agree to cooperate on restructuring, providing Goldsmith is elected to the board
Hostile Takeovers easier to swallow than poison pills
Analysis of poison pill defense